Tivorsan Pharmaceuticals Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Tivorsan Pharmaceuticals General Information

Description

Developer of novel therapeutic drugs designed to treat orphan neuromuscular diseases and disorders. The company's drugs are designed to treat serious neuromuscular disorders, including Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) as well as other progressive life-threatening neuromuscular disorders, enabling doctors to treat patients suffering from neuromuscular diseases and disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3 Davol Square
  • A340
  • Providence, RI 02903
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3 Davol Square
  • A340
  • Providence, RI 02903
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tivorsan Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 01-May-2021 Completed Out of Business
8. Secondary Transaction - Private 01-Nov-2020 Completed Generating Revenue
7. Later Stage VC 25-Oct-2018 Completed Generating Revenue
6. Later Stage VC (Series D) 17-Mar-2017 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Jan-2015 Completed Generating Revenue
4. Later Stage VC (Series B) 05-Jun-2013 Completed Generating Revenue
3. Grant 21-Feb-2012 Completed Generating Revenue
2. Grant 05-Jan-2012 $1M $1.12M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Feb-2011 $1.12M $1.12M Completed Generating Revenue
To view Tivorsan Pharmaceuticals’s complete valuation and funding history, request access »

Tivorsan Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 3,759,400 $0.010000 $0.09 $1.33 $1.33 1x $1.33 8.92%
Series A 3,472,223 $0.010000 $0.05 $0.72 $0.72 1x $0.72 8.24%
To view Tivorsan Pharmaceuticals’s complete cap table history, request access »

Tivorsan Pharmaceuticals Patents

Tivorsan Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013329296-A1 Biglycan variant polypeptides and methods of use Active 10-Oct-2012
AU-2013329296-A9 Biglycan variant polypeptides and methods of use Active 10-Oct-2012
AU-2013329296-B2 Biglycan variant polypeptides and methods of use Inactive 10-Oct-2012
CA-2887303-A1 Biglycan variant polypeptides and methods of use Inactive 10-Oct-2012
EP-2906292-A1 Biglycan variant polypeptides and methods of use Inactive 10-Oct-2012 C07K14/4725
To view Tivorsan Pharmaceuticals’s complete patent history, request access »

Tivorsan Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tivorsan Pharmaceuticals FAQs

  • When was Tivorsan Pharmaceuticals founded?

    Tivorsan Pharmaceuticals was founded in 2007.

  • Where is Tivorsan Pharmaceuticals headquartered?

    Tivorsan Pharmaceuticals is headquartered in Providence, RI.

  • What is the size of Tivorsan Pharmaceuticals?

    Tivorsan Pharmaceuticals has 6 total employees.

  • What industry is Tivorsan Pharmaceuticals in?

    Tivorsan Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Tivorsan Pharmaceuticals a private or public company?

    Tivorsan Pharmaceuticals is a Private company.

  • What is Tivorsan Pharmaceuticals’s current revenue?

    The current revenue for Tivorsan Pharmaceuticals is .

  • How much funding has Tivorsan Pharmaceuticals raised over time?

    Tivorsan Pharmaceuticals has raised $13.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process